Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

BUY
$98.98 - $115.74 $184,498 - $215,739
1,864 New
1,864 $215,000
Q2 2021

Aug 04, 2021

SELL
$86.24 - $95.92 $2.12 Million - $2.36 Million
-24,558 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$67.0 - $84.39 $323,878 - $407,941
4,834 Added 24.51%
24,558 $1.8 Million
Q3 2020

Oct 26, 2020

BUY
$55.23 - $79.93 $1.09 Million - $1.58 Million
19,724 New
19,724 $1.53 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Empowered Funds, LLC Portfolio

Follow Empowered Funds, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.